Complementing clinical cancer registry data with patient reported outcomes: A feasibility study on routine electronic patient-reported outcome assessment for the Austrian Myelome Registry

被引:15
|
作者
Sztankay, Monika [1 ,2 ,3 ]
Neppl, Lucia [2 ]
Wintner, Lisa M. [1 ,3 ]
Loth, Fanny L. [2 ]
Willenbacher, Wolfgang [4 ,5 ]
Weger, Roman [5 ]
Weyrer, Walpurga [4 ]
Steurer, Michael [4 ]
Rumpold, Gerhard [1 ]
Holzner, Bernhard [1 ,2 ]
机构
[1] Med Univ Innsbruck, Innsbruck, Tirol, Austria
[2] Univ Innsbruck Hosp, Psychiat 2, Anichstr 35, A-6020 Innsbruck, Tirol, Austria
[3] Univ Innsbruck, Innsbruck, Tirol, Austria
[4] Univ Innsbruck Hosp, Internal Med Haematol & Oncol 5, Innsbruck, Tirol, Austria
[5] Oncotyrol Ctr Personalized Canc Med, Innsbruck, Tirol, Austria
基金
奥地利科学基金会;
关键词
cancer registry; clinical routine; electronic patient-reported outcome monitoring; health-related quality of life; implementation; multiple myeloma; QUALITY; CARE; SURVEILLANCE; RATIONALE; SYMPTOMS; TRIALS;
D O I
10.1111/ecc.13154
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives Routinely assessed patient-reported outcomes (PROs), such as quality of life (QOL), are important to supplement clinical cancer data but requires rigorous implementation. This study aims at depicting the implementation procedure and evaluating the feasibility of routine electronic PRO monitoring (ePRO) for collecting data supplementing the Austrian Myeloma Registry (AMR). Methods Integration of ePRO monitoring into clinical routine was planned according to the Replicating Effective Programs framework. QOL data were assessed regularly during treatment and aftercare at the hematooncological outpatient unit at the Medical University of Innsbruck with the EORTC QLQ-C30/ +MY20 and the EQ-5D-5L. Feasibility and usability testing were performed via a multimethod approach. Results Within the first year, 94.4% of the MM patients (N = 142, mean age 65.4, SD 11.8, 60% male) provided 748 PRO assessment time points overall. Patients and clinicians were satisfied with ePRO monitoring and indicated no to little disruption in clinical routine. Patient preference on assessment time points and completion frequency became evident. Conclusions Complementing the AMR with ePRO data proved to be feasible. Our findings provide useful insights for healthcare providers considering introducing ePRO monitoring to their units for informing clinical registries as well as individualised feedback to patients alike.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Electronic Patient-Reported Outcomes as Digital Therapeutics to Improve Cancer Outcomes
    Basch, Ethan
    Mody, Gita N.
    Dueck, Amylou C.
    JCO ONCOLOGY PRACTICE, 2020, 16 (09) : 541 - +
  • [22] Patient-reported outcomes before treatment for localized prostate cancer: are there differences among countries? Data from the True North Global Registry
    Garin, O.
    Kowalski, C.
    Zamora, V.
    Roth, R.
    Ferrer, M.
    Breidenbach, C.
    Pont, A.
    Belin, T. R.
    Elashoff, D.
    Wilhalme, H.
    Nguyen, A. V.
    Kwan, L.
    Pearman, E. K.
    Bolagani, A.
    Sampurno, F.
    Papa, N.
    Moore, C.
    Millar, J.
    Connor, S. E.
    Villanti, P.
    Litwin, M. S.
    True North Global Registry
    BMC UROLOGY, 2023, 23 (01)
  • [23] Acceptability of patient reported outcome measures (PROMs) in a cystic fibrosis data registry
    Ratnayake, Irushi
    Ahern, Susannah
    Ruseckaite, Rasa
    BMJ OPEN RESPIRATORY RESEARCH, 2021, 8 (01)
  • [24] Feasibility of implementing a cervix cancer-specific patient-reported outcome measure in routine ambulatory clinics
    Atallah, Soha
    Barbera, Lisa
    Folwell, Matthew
    Howell, Doris
    Liu, ZhihuiAmy
    Croke, Jennifer
    SUPPORTIVE CARE IN CANCER, 2021, 29 (01) : 499 - 507
  • [25] Impact of immigration background on feasibility of electronic patient-reported outcomes in advanced urothelial cancer patients
    Yurdakul, Ozan
    Alan, Abdulkarim
    Krauter, Johanna
    Korn, Stephan
    Gust, Kilian
    Shariat, Shahrokh F.
    Hassler, Melanie R.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2024, 22 (01)
  • [26] Patient-reported outcomes for patients with breast cancer undergoing radiotherapy: A single-center registry experience
    Laughlin, Brady S.
    Bhangoo, Ronik S.
    Thorpe, Cameron S.
    Golafshar, Michael A.
    DeWees, Todd A.
    Anderson, Justin D.
    Vern-Gross, Tamara Z.
    McGee, Lisa A.
    Wong, William W.
    Halyard, Michele Y.
    Keole, Sameer R.
    Vargas, Carlos E.
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Using Electronic Data Collection Platforms to Assess Complementary and Integrative Health Patient-Reported Outcomes: Feasibility Project
    Haun, Jolie N.
    Alman, Amy C.
    Melillo, Christine
    Standifer, Maisha
    McMahon-Grenz, Julie
    Shin, Marlena
    Lapcevic, W. A.
    Patel, Nitin
    Elwy, A. Rani
    JMIR MEDICAL INFORMATICS, 2020, 8 (06)
  • [28] Ten Considerations for Integrating Patient-Reported Outcomes into Clinical Care for Childhood Cancer Survivors
    Horan, Madeline R.
    Sim, Jin-ah
    Krull, Kevin R.
    Ness, Kirsten K.
    Yasui, Yutaka
    Robison, Leslie L.
    Hudson, Melissa M.
    Baker, Justin N.
    Huang, I-Chan
    CANCERS, 2023, 15 (04)
  • [29] Reflections on estimands for patient-reported outcomes in cancer clinical trials
    Lawrance, Rachael
    Skaltsa, Konstantina
    Regnault, Antoine
    Floden, Lysbeth
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2023,
  • [30] Impact of Medium Cut-Off Dialyzers on Patient-Reported Outcomes: COREXH Registry
    Alarcon, Juan Carlos
    Bunch, Alfonso
    Ardila, Freddy
    Zuniga, Eduardo
    Vesga, Jasmin, I
    Rivera, Angela
    Sanchez, Ricardo
    Sanabria, Rafael Mauricio
    BLOOD PURIFICATION, 2021, 50 (01) : 110 - 118